HSCS

HeartSciences Inc.

NasdaqCMUSDEQUITY DELAYED

3.01

▲ 0.50 (19.92%)

MARKET · —

Price

Open

2.51

Prev close

2.51

Day high

2.87

Day low

2.47

Volume

139.70K

Market cap

—

P/E (TTM)

—

52W range

1.63 – 3.80

Trailing performance

Price return · vs SPY

Returnvs SPY

+35.92% +37.3%

+14.75% +11.0%

+44.33% +41.2%

-0.36% -11.4%

YTD

-9.39% -21.7%

-25.73% -45.7%

-96.36% -170.5%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

2.24

+34.17% from price

SMA 20

2.21

+26.80% from price

SMA 50

2.37

+18.00% from price

SMA 100

2.19

+37.54% from price

SMA 200

2.51

+11.47% from price

EMA 12

2.33

+29.24% from price

EMA 26

2.30

+30.71% from price

EMA 50

2.30

+30.82% from price

RSI (14)

65.3

Neutral

MACD (12,26,9)

0.03

Hist 0.08

ATR (14)

0.23

8.10% of price

Realised vol 30D

97.4%

Annualised

Bollinger upper

2.64

20, 2σ

Bollinger lower

1.78

20, 2σ

50 / 200 cross

Death

2.37 vs 2.51

Trend bias

Above 200

+11.47%

Risk profile

Daily returns · 1Y window

Beta vs SPY

0.02

Less volatile than market

Correlation to SPY

0.00

Largely independent

Realised vol 30D

97.4%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-55.5%

Peak to trough

Max drawdown 5Y

-99.5%

Peak to trough

ATR 14

0.23

8.10% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 3.01

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

HSCS · links out to the publisher

Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration GlobeNewswire · 3d ago HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results GlobeNewswire · 24d ago Zcash Miner Fortitude Powers Up Nebraska Facility as It Eyes Public Listing decrypt · 25d ago Fortitude Energizes 12 MW Grand Island, Nebraska Facility, Expanding Owned-and-Operated Power Portfolio Business Wire · 25d ago HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K GlobeNewswire · 30d ago Zcash Miner Fortitude Merging with HeartSciences to Go Public Exec Edge · 60d ago Top Midday Gainers MT Newswires · 60d ago BC-Most Active Stocks Associated Press · 60d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.